BCL-XL, an anti-apoptotic member of the BCL-2 protein family, is an attractive therapeutic target for overcoming apoptosis resistance in cancer. However, the large, shallow, and predominantly hydrophobic nature of its BH3-binding groove has complicated the discovery of potent, drug-like small-molecule inhibitors. Here,...
Hyunjin Kim, Ahyoung Jang, Sung-Woo Hong et al.· Journal of Molecular Graphic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.